Insight Molecular Diagnostics Inc. generated $4.1M in revenue in fiscal year 2025. This represents an increase of 115.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $1.7M in revenue. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Insight Molecular Diagnostics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMDX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
IMDX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Insight Molecular Diagnostics Inc. financials
Frequently Asked Questions
What was Insight Molecular Diagnostics Inc.'s revenue in fiscal year 2025?
Insight Molecular Diagnostics Inc. generated $4.1M in revenue in fiscal year 2025.
How fast is Insight Molecular Diagnostics Inc.'s revenue growing?
Insight Molecular Diagnostics Inc. (IMDX) revenue rose by 115.6% year over year, from $1.9M to $4.1M in fiscal year 2025.
What is Insight Molecular Diagnostics Inc.'s revenue over the last twelve months?
Insight Molecular Diagnostics Inc. (IMDX) reported $1.7M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Insight Molecular Diagnostics Inc.'s revenue in the most recent quarter?
Insight Molecular Diagnostics Inc. (IMDX) reported $239K in revenue in Q2 2026. This represents a decrease of 53.9% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Insight Molecular Diagnostics Inc. (IMDX) reported on that line in every period on record.